Is a complete PROK research report available?

No complete published report is available for ProKidney Corp. (PROK) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ProKidney Corp. (PROK)

NASDAQ: PROK · USD

$1.58

+0.04 (+2.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PROK analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	477.3M
Revenue (ttm)	889K
Net income (ttm)	-72.3M
EPS (ttm)	-$0.53
Shares out	302.1M
Volume	662,420
Beta	1.68
Price target	$6.25	+295.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 889K
Net income (ttm): -72.3M
EPS (ttm): -$0.53
Market cap: 477.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PROK indicators

Market & fundamental data

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001850270
Company name	ProKidney Corp.
Country	United States
Country code	US
Cusip	74291D104
Employees	231
Employees Change	27%
Employees Change Percent	13.24
Enterprise value	$254.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US74291D1046
Last refreshed	2026-07-31
Market cap	$477.3M
Market cap category	Small-Cap
Price	$1.58
Price currency	USD
Rev Per Employee	3,848.48x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2836
Symbol	PROK
Website	https://prokidney.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.19%
EV Sales Forward	453.54x
EV/Sales	286.37x
FCF yield	-31.54%
P/B ratio	1.81x
P/S ratio	535.15x
PS Forward	847.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-18,959.73%
EBITDA Margin	-18,213.61%
Gross margin	100%
Gross Profit	$889,000
Gross Profit Growth	190.52%
Gross Profit Growth Q	-1.74%
Net Income	$-72.3M
Net Income Growth Years	0%
Pretax Margin	-17,599.33%
Profit Per Employee	$-312,939
ROA	-30.15
Roa5y	-45.55
ROCE	-63.16
ROE	-49.37
Roe5y	-94.03
ROIC	-32.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-42.98%
Cagr3y	-49.03%
Cagr5y	-30.64%
EPS Growth Years	1
Revenue Growth	190.52x
Revenue Growth Q	-1.74x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$292.8M
Cash	$224.9M
Current Assets	$234.9M
Current Liabilities	$25.9M
Debt	$3.8M
Debt Equity	$0.01
Equity	$263.1M
Interest Coverage	-8,871.2
Liabilities	$29.7M
Long Term Assets	$57.9M
Long Term Liabilities	$3.7M
Net Cash	$221.2M
Net Cash By Market Cap	$46.49
Net Cash Growth	-31.98%
Net Debt Equity	$-0.84
Tangible Book Value	$-1B
Tangible Book Value Per Share	$-7.21
WACC	13.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.06
Net Working Capital	$-14.9M
Quick ratio	8.71
Working Capital	$209M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.33%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-42.96%
200-day SMA	2.11
3Y total return	-86.77%
50-day SMA	1.73
50-day SMA vs 200-day SMA	50under200
5Y total return	-83.94%
All Time High	14.19
All Time High Change	-88.87%
All Time High Date	2023-03-13
All Time Low	0.46
All Time Low Change	243.25%
All Time Low Date	2025-04-09
ATR	0.11
Beta	1.68
Beta1y	2.21
Beta2y	2.3
Ch YTD	-29.46
High	1.58
High52	3.55
High52 Date	2025-08-04
High52ch	-55.49%
Low	1.52
Low52	1.45
Low52 Date	2026-07-24
Low52ch	8.97%
Ma50ch	-8.46%
Premarket Change Percent	0
Premarket Price	$1.54
Premarket Volume	881
Price vs 200-day SMA	-25.26%
RSI	43.64
RSI Monthly	41.83
RSI Weekly	41.95
Sharpe ratio	-0.3x
Sortino ratio	-0.38
Total Return	-20.33%
Tr YTD	-29.46
Tr1m	-16.4%
Tr1w	3.95%
Tr3m	-13.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	2
Analyst Price Target Top	$12
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.14
Earnings Revenue Estimate	163,200x
Earnings Revenue Estimate Growth	-26.15x
Operating Income	$-168.6M
Operating margin	-18,959.7
Price target	$6.25
Price Target Change	$296
Price Target Change Top	$659

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	156,764,227%
Float Percent	51.9%
Net Borrowing	-17,000
Shares Insiders	12.36%
Shares Institutions	15.71%
Shares Out	302,059,626
Shares Qo Q	0.65%
Shares Yo Y	20.33%
Short Float	13.34%
Short Ratio	13.13
Short Shares	6.92

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-173.9M
Adjusted OCF	-156,074,000
Average Volume	1,106,369.1x
Bv Per Share	-7.21
CAPEX	$-17.8M
Ch1m	-16.4
Ch1w	3.95
Ch1y	-42.96
Ch3m	-13.19
Ch3y	-86.77
Ch5y	-83.94
Ch6m	-25.82
Change	2.6%
Change From Open	3.27
Close	1.54
Days Gap	-0.65
Depreciation Amortization	6,633,000
Dollar Volume	1,046,623.6
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-168.6M
EBITDA	$-161.9M
EPS	$-0.53
F Score	1
FCF	$-150.1M
FCF EV Yield	-58.94x
FCF Per Share	$-0.5
Financing CF	25,796,000
Fiscal Year End	December
Founded	2,015
Income Tax	$-177,000
Investing CF	110,503,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-18
Ma150	1.95
Ma150ch	-18.93%
Ma20	1.66
Ma20ch	-4.99%
Net CF	4,090,000
Next Earnings Date	2026-08-11
Open	1.53
Optionable	Yes
Position In Range	100
Post Close	1.58
Postmarket Change Percent	0.28
Postmarket Price	$1.58
Ppne	57,882,000
Pre Close	1.54
Price Date	2026-07-30
Relative Volume	0.6x
Revenue	889,000x
SBC By Revenue	2,684.48x
Share Based Comp	23,865,000
Tax By Revenue	-19.91x
Tr6m	-25.82%
Us State	North Carolina
Volume	662,420
Z Score	-1.51

ProKidney Corp. (PROK)

Coverage state: Market snapshot only — no published research

Generate the first PROK analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PROK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PROK indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PROK

Frequently asked questions